Gabalex Capital Management LLC Merck & Co., Inc. Transaction History

Gabalex Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$84.53 - $94.96 $1.69 Million - $1.9 Million	20,000 Added 20.0%	120,000 $10.3 Million
Q4 2021 Feb 02, 2022	SELL	$72.28 - $90.54 $4.34 Million - $5.43 Million	-60,000 Reduced 37.5%	100,000 $7.66 Million
Q2 2021 Aug 03, 2021	BUY	$70.31 - $77.77 $703,100 - $777,700	10,000 Added 6.67%	160,000 $12.4 Million
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $614,231 - $723,501	8,920 Added 6.32%	150,000 $11.6 Million
Q4 2020 Feb 03, 2021	SELL	$71.77 - $79.65 $2.43 Million - $2.7 Million	-33,920 Reduced 19.38%	141,080 $11.5 Million
Q3 2020 Nov 03, 2020	BUY	$73.18 - $82.95 $3.66 Million - $4.15 Million	50,000 Added 40.0%	175,000 $14.5 Million
Q2 2019 Aug 01, 2019	BUY	$69.84 - $81.59 $1.75 Million - $2.04 Million	25,000 Added 25.0%	125,000 $10.5 Million
Q4 2017 Feb 01, 2018	SELL	$51.62 - $61.64 $2.58 Million - $3.08 Million	-50,000 Reduced 33.33%	100,000 $5.63 Million
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $8.8 Million - $9.47 Million	150,000	150,000 $9.61 Million

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Gabalex Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gabalex Capital Management LLC with notifications on news.